• New contact lenses filter 60% associated with blue-violet light *1
  • Designed to lock in moisture for visual clarity and all-day comfort 1, 2
  • Multifocal lenses with regard to presbyopic patients provide crisp, clear vision at all distances and in all lighting conditions plus all-day comfort 3

JACKSONVILLE, Fla. , Sept. 12, 2022 /PRNewswire/ —  Johnson & Johnson Vision Care, Inc., a global leader in eye health and part of Johnson & Manley MedTech, today announced the particular launch of its newest innovation, ACUVUE ® OASYS MAX 1-DAY contact lenses and ACUVUE ® OASYS MAXIMUM 1-Day MULTIFOCAL contact lenses regarding presbyopia.   Designed with an unprecedented combination of new technologies to help meet the needs of digitally intense lifestyles: TearStable™ Technology and OptiBlue™ gentle filter. 1 TearStable™ Technology is designed to maximize tear-film stability plus lock in moisture for exceptional all-day comfort and ease. 1, 2 The OptiBlue™ lighting filter has the highest level blue-violet filter in the industry at 60% §, *   to reduce light scatter for outstanding visual clearness, day in order to night. 2 In addition , ACUVUE ® OASYS MAX 1-Day lenses block 99. 9% UVA rays and 100% UVB sun rays. **, ††, 4, 5

“Life has changed, post-pandemic. With more time spent on digital devices, 6 we designed these disposable lenses by listening to patients and eye care professionals’ feedback to address lifestyle requirements and help prevent dry and tired eyes from becoming normalized, ” said John Buch , OD, Senior Principal Research Optometrist, Johnson & Johnson Eyesight. ‡‡   “Our brand new ACUVUE ® OASYS MAX 1-Day contact lens help reduce discomfort by providing visual clarity with new technologies to filtration system blue-violet light, * which comes from many sources, including digital screens and travels in short wavelengths plus scatters more which can lead to vision discomfort and quality associated with vision. ” 7

Adults are now spending 13+ hours a day on digital products, a 35% increase since 2019. 6 When looking at the digital screen, you blink 60% less, which could destabilize the tear film, impacting comfort plus vision. 8, 9 Blue-violet light scatters through digital displays, fluorescent/LED lights and the sun, which can impact visual clarity. 7 These demands are even more troubling for aging eyes. While digital display use destabilizes the rip film at all ages, the tear film breaks down 50% faster by age 50 and may exacerbate the feelings of dried out eye and impact consistency of eyesight. 10 Meanwhile, light scatter doubles by age group 60, resulting in increased visible artifacts (starbursts, halos), affecting distance vision, and contributing to decreased ability to drive at night or read in dim light. 11  

For patients along with presbyopia (a condition that happens to everyone around age 40 negatively impacting near vision, particularly in poor light), ACUVUE ® OASYS GREATEST EXTENT 1-Day MULTIFOCAL  contact lenses provide sharp, clear eyesight whatsoever ranges and almost all lighting problems, as well as all-day comfort. 3 The particular lenses combine the same two powerful systems – TearStable™ Technology plus the OptiBlue™ light filter – plus PUPIL OPTIMIZED DESIGN technology, which tailors 100% of parameters to pupil size variations across both age group and refraction compared in order to less than 2% for the leading competitor, intended for exceptionally effortless vision. §§, a few, 12 This is the particular same technologies that is available throughout all ACUVUE ® Multifocal get in touch with lenses. 12

“I’ve witnessed more individuals facing symptoms related to a destabilized tear film such as dryness and inconsistent vision due to our increasingly digital lifestyles. It’s important for just about all contact lens users to have the latest innovative treatment options available to help tackle comfort and clarity to meet their lifestyle requirements, ” said Luis Rojas , OD, co-founder of DeNovo Eye . *** “ACUVUE ® OASYS MAX 1-Day uses innovative technology, designed to maximize rip film stability and reduce light spread to maintain increased visual clearness and all-day comfort. inch 2., †††, one, 2, 13

ACUVUE ® OASYS UTMOST 1-Day builds on the ACUVUE ® OASYS portfolio of products, which is unbeaten in comfort across 31 clinical trials. ‡‡‡   In clinical trials of ACUVUE ® OASYS POTENTIAL 1-Day, 90% of wearers reported all-day comfort plus a reduction in exhausted eyes from digital gadgets, with nearly 100% reporting clear, reliable vision. two

Earlier this year , ACUVUE ® OASYS MAX 1-Day and ACUVUE ®   OASYS MAX 1-Day MULTIFOCAL received U. S. Food & Drug Administration (FDA) clearance, Health Canada approval plus completed CE Mark activities for its current lens development.

The lenses are available right now in spherical and multifocal.   To find a good ECP and schedule an appointment, please visit here . For more information plus to stay informed associated with product availability, please check out:   https://www.jnjvisionpro.com/oasys-max-family and for Instructions for Use, please click here .

About Johnson & Johnson Vision
At Johnson & Johnson Eyesight, part of Johnson & Manley MedTech, we have a bold ambition: to change the trajectory of attention health around the world. Through our own operating companies, we deliver innovation that enables eyesight care professionals to create better outcomes for sufferers throughout their lives, with products and technology that deal with unmet needs including refractive error, cataracts and dry eye. In communities along with greatest need, we work in collaboration to expand access in order to quality eyes care, plus we are usually committed to helping people see better, connect much better and live better. Visit us in www.jjvision.com . Follow @JNJVision on Twitter and Johnson & Johnson Vision upon LinkedIn, and @JNJVision on Facebook.

About Johnson & Manley MedTech
At Johnson & Manley MedTech, all of us unleash diverse healthcare expertise, purposeful technology, and a passion for people in order to transform the future of medical intervention and empower everyone to live their best life possible. For a lot more than a century, we have driven breakthrough scientific innovation in order to address unmet needs plus reimagine health. In surgery, orthopedics, vision, and interventional solutions, we all continue to help save lives and create the future where healthcare solutions are smarter, less invasive, and more personalized.

Important Information to get Lens Wearers:  
ACUVUE ®   Contact Lenses are available by prescription only for eyesight correction. An eye treatment professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing lenses. In order to help avoid these problems, follow the particular wear and replacement schedule as well as the lens care instructions provided by your eye doctor. Do not wear contacts if you have an eye infection, or experience eye pain, excessive tearing, vision changes, redness or other vision problems. If one associated with these circumstances occurs, remove the zoom lens and contact your attention doctor immediately. For more information upon proper put on, care plus safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020, or even download the Patient Training Guide ( https://www.acuvue.com/patient-instruction-guides ).

Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined inside the Private Securities Litigation Reform Act of 1995 regarding ACUVUE ® MAX 1-Day. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events.   In case underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections associated with Johnson & Johnson Eyesight Care, Incorporation. and/or Johnson & Manley.   Risks and uncertainties include but are not limited to: uncertainty of commercial success; challenges in order to patents; competition, including technological advances, new products plus patents attained by competitors; manufacturing difficulties and delays; changes to applicable laws and regulations, including global health treatment reforms; modifications in behavior and spending patterns of purchasers associated with health care items and services; and trends toward wellness care cost containment.   A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the particular fiscal 12 months ended January 2, 2022 , which includes in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors, inches and in Johnson & Johnson’s subsequent Quarterly Reports upon Form 10-Q along with other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov , www.jnj.com or on request through Johnson & Johnson. Neither Johnson & Johnson Vision Care, Inc. nor Manley & Johnson undertakes in order to update any forward-looking statement as a result of brand new information or even future occasions or developments.

* Filtering of HEV light by for the purpose of offers not been demonstrated to confer any kind of health benefit to the user, including but not restricted to retinal protection, protection from cataract progression, reduced eyesight strain, improved contrast, enhanced acuity, reduced glare, improved low gentle vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for a lot more information.
Johnson & Johnson Eyesight represents the products and solutions of Manley & Johnson Surgical Vision, Inc., Manley & Johnson Vision Treatment, Inc., and the affiliates associated with both.
Johnson & Johnson MedTech comprises the surgery, orthopaedics, vision plus interventional solutions businesses within Johnson & Johnson’s MedTech segment.
§ Versus publicly available information for standard daily use contact lens as of July 2022 .
** Helps protect against transmission of harmful UV radiation towards the cornea & into the eyes.
††   WARNING: UV-absorbing disposable lenses are the NOT substitutes pertaining to protective UV-absorbing eyewear like UV-absorbing goggles or sunglasses because they do not completely cover the particular eye and surrounding area. You ought to continue to use UV-absorbing eyewear because directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on the number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful ULTRAVIOLET radiation. However, clinical studies have not really been done to demonstrate that putting on UV-blocking get in touch with lenses reduces the risk of developing cataracts or even other eye disorders. Consult your vision care practitioner for more information.
‡‡ John Buch , OD is an employee associated with Johnson & Johnson Eyesight Care, Incorporation. with oversight as Senior Principal Research Optometrist of the Vision Care organization.
§§ Compared in order to competitor’s designs, technology optimized for both the parameters of refractive error plus add power.
***   Luis Rojas, Z, is a paid consultant of Johnson & Johnson Vision, Inc.
††† Versus ACUVUE OASYS 1-Day.
‡‡‡ ClinicalTrials. gov will be a website maintained by the NIH. The 31 medical studies evaluated subjective convenience as a primary or secondary endpoint for ACUVUE OASYS Brand 2-weekly family and meant for ACUVUE OASYS 1-Day along with HydraLuxe Technology Brand family members contact lens. Review conducted since April 29, 2022 .
1 JJV Data on File 2022. TearStable Technology Definition.
2 JJV Data on File, 2022. CSM Subjective Responses ACUVUE OASYS MAXIMUM 1-Day Contact Lenses- Retrospective Meta-analysis.
three or more JJV Information on Document 2022. Very subjective Stand-Alone Claims for ACUVUE OASYS GREATEST EXTENT 1-Day MULTIFOCAL Contact Lenses — Exploratory Meta-analysis.
4 JJV Data upon File 2022. Material Properties: 1-DAY ACUVUE MOIST, 1-DAY ACUVUE TruEye, ACUVUE OASYS 1-Day with HydraLuxe Technologies and ACUVUE OASYS UTMOST 1-Day along with TearStable Technology Brand Get in touch with Lenses.
5 JJV Data on File 2022: Master Brand Statements on Clinical Performance and Overall Material Properties designed for ACUVUE Brand name Soft Disposable lenses.
6 COVID-19: Screen Time spikes to over 13 hours per day according to Eyesafe Nielsen estimates, published 3/28/20, https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day3 .
7   JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE ® OASYS POTENTIAL 1-Day Contact Lenses.
8 Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993; 328(8): 584. doi: 10. 1056/NEJM199302253280817.
9 Patel S, Henderson R, Bradley L, et al. Effect of visual display unit make use of on blink rate plus tear balance. Optom Vis Sci 1991; 68(11): 888-892. doi: ten. 1097/00006324-199111000-00010.
10 Mostafa Y, SaifM, Saeed M, and ElSaadanyS. The Effect of Age and Gender on Tear Film Breakup Time. Egyptian Journal associated with Medical Study. 2021; 2: 137-148.
11 Van Den Berg TJ, Van Rijn LJ, Michael R, ainsi que al. Straylight effects with aging plus lens extraction. Am J Ophthalmol2007; 144(3): 358-363.
twelve JJV Information on file 2022. CSM- ACUVUE PUPIL OPTIMIZED DESIGN Technology: JJVC contact lenses, design features, and associated benefits.
13 JJV Data upon File 2022. Effect on Rip Film plus Evaluation of Visual Artifacts with ACUVUE OASYS MAX 1-Day Family.

SOURCE Manley & Johnson Eyesight

Leave a Reply

Your email address will not be published.